Navigation Links
Molecule in Skin May Link Eczema and Asthma
Date:5/19/2009

Finding in mice might explain progression from skin to breathing condition

TUESDAY, May 19 (HealthDay News) -- A substance secreted by eczema-damaged skin might trigger asthma in children, U.S. researchers suggest.

The theory comes from a study of mice with an eczema-like condition, which suggested that early treatment of eczema and inhibition of the trigger substance might help prevent asthma.

An estimated 50 percent to 70 percent of children with severe eczema, known as atopic dermatitis, develop asthma, compared with about 9 percent of children in the general population. In the United States, about 17 percent of children have eczema, although not all cases are severe.

The progression from eczema to asthma is called the atopic march.

"Over the years, the clinical community has struggled to explain atopic march," Raphael Kopan, a professor of developmental biology and dermatology at Washington University School of Medicine in St. Louis and an author of the study, said in a news release from the school.

"So, when we found that the skin of mice with an eczema-like condition produced a substance previously implicated in asthma, we decided to investigate further," Kopan said. "We found that the mice also suffered from asthma-like responses to inhaled allergens, implicating the substance, called TSLP, as the link between eczema and asthma."

The researchers found that TSLP (thylmic stromal lymphopoietin) is secreted by damaged skin to alert the body that the skin's protective barrier has failed. TSLP activates an immune response that fights invaders.

"We are excited, because we've narrowed down the problem of atopic march to one molecule," Kopan said. "We've shown that skin can act as a signaling organ and drive allergic inflammation in the lung by releasing TSLP. Now, it will be important to address how to prevent defective skin from producing TSLP."

"If that can be
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. New class of RNA molecules may be important in human cancer
2. Molecule Promising Against Huntingtons Disease
3. Free Access to Literature Data on Chagas Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with archive mine and collaborate access to small molecule bioactivity SAR data on parasitic disease
4. Vulnerability to Stress Linked to Brain Molecule
5. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
6. Study Describes Molecules That Control Blood Pressure
7. Researchers identify molecules with interesting anti-clotting properties
8. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
9. St. Jude finds molecule that could improve cancer vaccines and therapy for other diseases
10. Major Advance in the Observation of DNA Molecules
11. Molecules can block breast cancers ability to spread
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecule in Skin May Link Eczema and Asthma
(Date:5/18/2013)... (PRWEB) May 18, 2013 John Ravera, D.D.S., ... the addition of a new member to his dental team, ... worked in the field for over 10 years. She received ... honors, and was elected a member of Sigma Pi Alpha, ... profession. Marino enjoys working with patients of all ages, helping ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... 2013 Creation's Gold has released its ... which features unmatched potency and purity that serves to ... up to provide the very best quality products to ... their wellness goals. The goal is to provide people ... lives. We started by supplying only the best premium ...
(Date:5/17/2013)... NEW YORK, May 18, 2013. Chronic trauma can inflict ... anxiety. Previous imaging studies of people with post-traumatic stress ... can over-or under-react in response to stressful tasks, such ... photo of a threatening face. Now, researchers at NYU ... what happens in the brains of combat veterans with ...
(Date:5/17/2013)... Daily Gossip announced on Monday that their reporters ... Program Yourself Thin regime, Jim Katsoulis. , ... the end of the month in order to teach readers ... and lead a healthy lifestyle, free of food cravings and ... is available for only $97 and it comes with six ...
Breaking Medicine News(10 mins):Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour ... indoor and outdoor allergy symptoms. The product is available for ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) , ...
... , , , ... workers in today,s economy add additional stress to already overworked employees, ... National Safety Council estimates that employers pay almost $1 billion per ... indirect costs related to workers, compensation. , , ...
... September 2009: The REVISE Study (Reveal in the Investigation of ... in the United Kingdom, previously thought to be suffering from ... fact had symptoms as a result of an abnormal pattern ... REVISE is the first study to show that, ...
... VidaGas propane energy company secures $1.4M investment from ... Sept. 1 VillageReach, the Seattle-based social enterprise that increases ... Foundation for Community Development (FDC), a Mozambique non profit that ... Oasis Fund, a European commercial investment fund specializing in social ...
... ... a Complete Electronic System to ,Improve Patient Care , ... Atlanta, GA (Vocus) September 1, 2009 -- Thousands ... health records. While this has made improvements in patient care, an electronic health records ...
... BUENOS AIRES, Argentina, Sept. 1 Frost & ... 2009 Customer Value Leadership Award in the Latin American computed ... continuously add value to new and existing healthcare providers, positioning ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , ...
Cached Medicine News:Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 2Health News:Workers' Compensation Networks Evolve to Meet Changing Needs of Today's Market 3Health News:Syncope and implantable loop recorders: Good value for money? 2Health News:Syncope and implantable loop recorders: Good value for money? 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 2Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 4Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 2Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 3Health News:Electronic Information Exchange Is Critical to Closing the Gap in Health Care Reform 4Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 2Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 3Health News:Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award 4
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - ... today,announced that data from a 36-week, randomized, ... oral 0.6 mg,dose of laquinimod given daily ... by 38 percent in RRMS,patients and was ...
... pivotal phase III study in women with recurrent ... 2007,/PRNewswire-FirstCall/ -- A new study further supports the ... being,studied for the treatment of ovarian cancer. The ... protein, which triggers,a series of events that selectively ...
Cached Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5
... Surgical Markers allows the surgeon ... with a scrub-resistant, gentian violet ... are provided sterile, with a ... in peel pouches. Micro tip ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Broad tip, gentian violet, sterile, disposable...
Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide....
Medicine Products: